- Earlier postoperative ctDNA detection predicts recurrence and adjuvant therapy benefit in stage II-III colorectal cancer. Zhang, W., Xu, C., Wang, J. et al. npj Precision Oncology. 2026. https://doi.org/10.1038/s41698-026-01497-9
- (Download PDF)
-
Products
Sectors
Categories
